PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30229843-7	2018	Compared with that in Group C, the expressions of p-p38MAPK and p-ATF-2 in Group D were significantly downregulated after injection of SB203580 (p<0.05).	SB 203580	135-143	activating transcription factor 2	Rattus norvegicus	66-71	
22776617-9	2012	SB203580 could reduce the phosphorylation of p38 and its substrate, ATF2, including the upregulation of total caspase-3 expression in the DRG.	SB 203580	0-8	activating transcription factor 2	Rattus norvegicus	68-72	
12960040-8	2003	SB 203580 (a specific p38 MAPK inhibitor) attenuated glucosamine action on ANG gene expression as well as p38 MAPK and ATF-2 phosphorylation, but not that of CREB.	SB 203580	0-9	activating transcription factor 2	Rattus norvegicus	119-124	
9422727-3	1998	Herein, we report that transactivation of grp78, as well as phosphorylation/activation of ATF-2, can be completely annihilated by SB203580, a highly specific inhibitor of p38 mitogen-activated protein kinase (p38(MAPK)).	SB 203580	130-138	activating transcription factor 2	Rattus norvegicus	90-95